CompletedNot Applicable

Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia

Turkey (Türkiye)132 participantsStarted 2019-06-20

Plain-language summary

The purpose of this study is to compare the efficacy of the vaginal micronized progesterone and Levonorgestrel-releasing Intrauterine System for treatment of non-atypical endometrial hyperplasia in premenopausal women.

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Premenopausal Patients * Patients with histologically confirmed endometrial hyperplasia without atypia Exclusion Criteria: * Endometrial hyperplasia with atypia * Endometrial Carcinoma * Suspected pathology on Physical/Ultrasonographic Examination e.g. fibroids, adnexal abnormality

What they're measuring

Regression and remission rate of endometrial hyperplasia

Timeframe: 3 month

Trial details

NCT IDNCT03992937

SponsorKocaeli University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-01

View on ClinicalTrials.gov More Endometrial Hyperplasia Without Atypia trials